← FDA DRUG APPROVALS

FDA ANDA · ANDA070819

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA070819
TYPE
ANDA
ORIGINAL APPROVAL
1987-07-10
LATEST ACTION
1998-09-18
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/5ML · SOLUTION · ORAL

Approval history

1998-09-18Manufacturing (CMC) · Supplement 22AP
1997-05-13Manufacturing (CMC) · Supplement 21AP
1996-03-11Labeling · Supplement 20AP
1995-02-16Manufacturing (CMC) · Supplement 19AP
1994-09-06Manufacturing (CMC) · Supplement 18AP
1994-03-10Labeling · Supplement 17AP
1993-12-06Manufacturing (CMC) · Supplement 16AP
1993-09-21Labeling · Supplement 15AP
1993-06-02Manufacturing (CMC) · Supplement 13AP
1993-03-18Labeling · Supplement 14AP
1992-06-17Labeling · Supplement 12AP
1991-03-12Labeling · Supplement 11AP
1990-09-06Labeling · Supplement 9AP
1989-03-14Labeling · Supplement 8AP
1989-01-18Manufacturing (CMC) · Supplement 7AP
1988-06-06Manufacturing (CMC) · Supplement 6AP
1988-05-05Manufacturing (CMC) · Supplement 5AP
1987-10-26Manufacturing (CMC) · Supplement 1AP
1987-09-30Manufacturing (CMC) · Supplement 2AP
1987-09-30Manufacturing (CMC) · Supplement 3AP
1987-07-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →